Patents by Inventor Matt Sweeney

Matt Sweeney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11085061
    Abstract: The present invention relates to compositions comprising: a polypeptide having cellulolytic enhancing activity and a liquor. The present invention also relates to methods of using the compositions.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: August 10, 2021
    Assignees: Novozymes, Inc., Novozymes North America, Inc.
    Inventors: Jason Quinlan, Feng Xu, Matt Sweeney, Don Higgins, Hui Xu
  • Publication number: 20210230522
    Abstract: Disclosed are devices and methods that allow for the capture and retention of grain aroma that would otherwise be lost or reduced in distilled spirits production processes. Devices and methods are disclosed that allow for the capture and retention of aromas released during grain heating. Devices and methods are disclosed that allow for the capture and retention of grain aromas prior to the loss of these aromas in subsequent mashing, fermentation, and distillation processes. In one embodiment, captured and retained aromas from a particular grain are added back to the spirit distillate produced from that same grain. In one embodiment, the grain from which aroma is extracted is subsequently mashed, fermented, distilled and rejoined with the aromatized spirit to produce a rejoined spirit. Devices and methods are disclosed which utilize the grain aroma extraction process as a source of heat for the cooking of grain in subsequent or parallel mashes.
    Type: Application
    Filed: January 28, 2020
    Publication date: July 29, 2021
    Inventors: Matt Sweeney, Douglas J. Boyle, III, Jason Somerby
  • Patent number: 10793845
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity, catalytic domains, cellulose binding domains and polynucleotides encoding the polypeptides, catalytic domains or cellulose binding domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or cellulose binding domains.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: October 6, 2020
    Assignees: Novozymes A/S, Novozymes, Inc.
    Inventors: Nikolaj Spodsberg, Tarana Shaghasi, Matt Sweeney, Feng Xu, Kirk Schnorr
  • Publication number: 20190316103
    Abstract: The present invention relates to GH61 polypeptide variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: May 23, 2019
    Publication date: October 17, 2019
    Applicants: NOVOZYMES, INC., Novozymes A/S
    Inventors: Janine Lin, Doreen Bohan, Michelle Maranta, Leslie Beresford, Michael Lamsa, Bjarne Gram Hansen, Frank Winther Rasmussen, Matt Sweeney, Douglas J. Boyle III
  • Publication number: 20190316106
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity, catalytic domains, cellulose binding domains and polynucleotides encoding the polypeptides, catalytic domains or cellulose binding domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or cellulose binding domains.
    Type: Application
    Filed: June 3, 2019
    Publication date: October 17, 2019
    Applicants: Novozymes A/S, Novozymes, Inc.
    Inventors: Nikolaj Spodsberg, Tarana Shaghasi, Matt Sweeney, Feng Xu, Kirk Schnorr
  • Publication number: 20190300922
    Abstract: The present invention relates to compositions comprising: a polypeptide having cellulolytic enhancing activity and a liquor. The present invention also relates to methods of using the compositions.
    Type: Application
    Filed: April 25, 2019
    Publication date: October 3, 2019
    Applicants: Novozymes, Inc., Novozymes North America, Inc.
    Inventors: Jason Quinlan, Feng Xu, Matt Sweeney, Don Higgins, Hui Xu
  • Publication number: 20190291285
    Abstract: A tool-holding arm includes a plurality of links and a tool coupling that removably secures a tool to the tool-holding arm. A first fluid spring provides a gravity-counteracting force to the tool-holding arm. A locking mechanism selectively locks the first fluid spring. An adjustment mechanism selectively adjusts an amount of the gravity-counteracting force provided by the first fluid spring.
    Type: Application
    Filed: January 20, 2017
    Publication date: September 26, 2019
    Applicant: Ekso Bionics, Inc.
    Inventors: Adam PREUSS, Chris MEADOWS, Kurt AMUNDSON, Russ ANGOLD, James LUBIN, Mario SOLANO, Tom MASTALER, Nicholas FLEMING, Matt SWEENEY
  • Patent number: 10351834
    Abstract: The present invention relates to GH61 polypeptide variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: November 21, 2012
    Date of Patent: July 16, 2019
    Assignees: Novozymes, Inc., Novozymes A/S
    Inventors: Janine Lin, Doreen Bohan, Michelle Maranta, Leslie Beresford, Michael Lamsa, Bjarne Gram Hansen, Frank Winther Rasmussen, Matt Sweeney, Douglas J. Boyle, III
  • Patent number: 10336993
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity, catalytic domains, cellulose binding domains and polynucleotides encoding the polypeptides, catalytic domains or cellulose binding domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or cellulose binding domains.
    Type: Grant
    Filed: September 6, 2018
    Date of Patent: July 2, 2019
    Assignees: Novozymes A/S, Novozymes, Inc.
    Inventors: Nikolaj Spodsberg, Tarana Shaghasi, Matt Sweeney, Feng Xu, Kirk Schnorr
  • Patent number: 10327536
    Abstract: An exoskeleton includes strapping for coupling the exoskeleton to a wearer. The exoskeleton also includes a hip structure, a thigh link rotatably connected to the hip structure and a shank link rotatably connected to the thigh link. The weight of the exoskeleton is transferred to a surface on which the exoskeleton is standing through the hip structure, the thigh link and the shank link. An arm brace supports an arm of the wearer, and a telescopic link is rotatably connected to the arm brace. An energy storage device delivers power to a tool through a conduit, and a conduit-energy storage device coupling connects the conduit to the energy storage device.
    Type: Grant
    Filed: October 31, 2016
    Date of Patent: June 25, 2019
    Assignee: Ekso Bionics, Inc.
    Inventors: Adam Pruess, Chris Meadows, Kurt Amundson, Russ Angold, James Lubin, Mario Solano, Tom Mastaler, Nicholas Fleming, Matt Sweeney
  • Patent number: 10316343
    Abstract: The present invention relates to compositions comprising: a polypeptide having cellulolytic enhancing activity and a liquor. The present invention also relates to methods of using the compositions.
    Type: Grant
    Filed: June 7, 2016
    Date of Patent: June 11, 2019
    Assignees: Novozymes, Inc., Novozymes North America, Inc.
    Inventors: Jason Quinlan, Feng Xu, Matt Sweeney, Don Higgins, Hui Xu
  • Publication number: 20190153414
    Abstract: The present invention relates to GH61 polypeptide variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: February 6, 2019
    Publication date: May 23, 2019
    Applicants: Novozymes, Inc.
    Inventors: Janine Lin, Doreen Bohan, Michelle Maranta, Leslie Beresford, Michael Lamsa, Matt Sweeney, Mark Wogulis, Elizabeth Znameroski, Frank Winther Rasmussen
  • Patent number: 10245204
    Abstract: A mobility system includes an energy module, an exoskeleton and a mobile base. The exoskeleton has an exoskeleton energy module receptacle that can receive the energy module, and the mobile base has a mobile base energy module receptacle that can also receive the energy module. In addition, the mobile base has an exoskeleton support that can support the exoskeleton on the mobile base so that the mobile base can transport the exoskeleton across a support surface.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: April 2, 2019
    Assignee: Ekso Bionics, Inc.
    Inventors: Reuben Sandler, Renata Smith, Chris Meadows, Rochelle Rea, Jared Jones, Matt Sweeney
  • Patent number: 10227579
    Abstract: The present invention relates to GH61 polypeptide variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: April 26, 2013
    Date of Patent: March 12, 2019
    Assignees: Novozymes A/S, Novozymes, Inc.
    Inventors: Janine Lin, Doreen Bohan, Michelle Maranta, Leslie Beresford, Michael Lamsa, Matt Sweeney, Mark Wogulis, Elizabeth Znameroski, Frank Winther Rasmussen
  • Publication number: 20190002858
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity, catalytic domains, cellulose binding domains and polynucleotides encoding the polypeptides, catalytic domains or cellulose binding domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or cellulose binding domains.
    Type: Application
    Filed: September 6, 2018
    Publication date: January 3, 2019
    Applicants: Novozymes A/S, Novozymes, Inc.
    Inventors: Nikolaj Spodsberg, Tarana Shaghasi, Matt Sweeney, Feng Xu, Kirk Schnorr
  • Patent number: 9994833
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and polynucleotides encoding the polypeptides, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: June 12, 2018
    Assignees: Novozymes A/S, Novozymes, Inc.
    Inventors: Ye Liu, Tarana Shaghasi, Matt Sweeney
  • Patent number: 9982285
    Abstract: The present invention relates to polypeptides having cellulolytic enhancing activity, catalytic domains, and carbohydrate binding domains, and polynucleotides encoding the polypeptides, catalytic domains, and carbohydrate binding domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains, and carbohydrate binding domains.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: May 29, 2018
    Assignees: Novozymes A/S, Novozymes, Inc.
    Inventors: Kirk Schnorr, Tarana Shaghasi, Matt Sweeney
  • Publication number: 20180060504
    Abstract: Prediction of the physiological effect of phytotherapeutic products and the recommendation of phytotherapeutic products on the basis of physiological effects are provided. A first product profile includes a plurality of compound identifiers and a plurality of concentrations. Observational data is read regarding a plurality of subjects who have consumed a first product substantially conforming with the first product profile. From the observational data a first set of physiological effects is determined associated with the first product profile. In some embodiments, a second set of physiological effects associated with a second product profile is determined based on the first product profile, the second product profile, and the first set of physiological effects. In other embodiments, a second product profile associated with a second set of physiological effects is determined based on the first product profile, the first set of physiological effects, and the second set of physiological effects.
    Type: Application
    Filed: August 23, 2017
    Publication date: March 1, 2018
    Inventors: Michael S. Clemmons, Matt Sweeney
  • Publication number: 20170362622
    Abstract: The present invention relates to polypeptides having cellulolytic enhancing activity, catalytic domains, and carbohydrate binding domains, and polynucleotides encoding the polypeptides, catalytic domains, and carbohydrate binding domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains, and carbohydrate binding domains.
    Type: Application
    Filed: August 31, 2017
    Publication date: December 21, 2017
    Inventors: Kirk Schnorr, Tarana Shaghasi, Matt Sweeney
  • Patent number: 9816082
    Abstract: The present invention relates to polypeptide having cellulolytic enhancing activity variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: September 29, 2011
    Date of Patent: November 14, 2017
    Assignee: Novozymes, Inc.
    Inventors: Matt Sweeney, Mark Wogulis